Your browser doesn't support javascript.
loading
Glioblastoma: Relationship between Metabolism and Immunosuppressive Microenvironment.
Hernández, Ainhoa; Domènech, Marta; Muñoz-Mármol, Ana M; Carrato, Cristina; Balana, Carmen.
Afiliação
  • Hernández A; B·ARGO (Badalona Applied Research Group of Oncology) Medical Oncology Department, Catalan Institute of Oncology Badalona, 08916 Badalona, Spain.
  • Domènech M; B·ARGO (Badalona Applied Research Group of Oncology) Medical Oncology Department, Catalan Institute of Oncology Badalona, 08916 Badalona, Spain.
  • Muñoz-Mármol AM; Pathology Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • Carrato C; Pathology Department, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • Balana C; B·ARGO (Badalona Applied Research Group of Oncology) Medical Oncology Department, Catalan Institute of Oncology Badalona, 08916 Badalona, Spain.
Cells ; 10(12)2021 12 14.
Article em En | MEDLINE | ID: mdl-34944036
Glioblastoma (GBM) is the most aggressive brain tumor in adults and is characterized by an immunosuppressive microenvironment. Different factors shaping this tumor microenvironment (TME) regulate tumor initiation, progression, and treatment response. Genetic alterations and metabolism pathways are two main elements that influence tumor immune cells and TME. In this manuscript, we review how both factors can contribute to an immunosuppressive state and overview the strategies being tested.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Imunossupressão / Glioblastoma / Microambiente Tumoral Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Imunossupressão / Glioblastoma / Microambiente Tumoral Idioma: En Ano de publicação: 2021 Tipo de documento: Article